勘误：《气体驱动纳米马达通过调节肠道免疫环境-血液结合素-微生物群回路缓解结肠炎》[《药学学报B》14 (2024) 2732-2747]的作者更正。
Erratum: Author correction to "Gas-propelled nanomotors alleviate colitis through the regulation of intestinal immunoenvironment-hematopexis-microbiota circuits" [Acta Pharm Sin B 14 (2024) 2732-2747].
作者信息
Xiao Bo, Liang Yuqi, Liu Ga, Wang Lingshuang, Zhang Zhan, Qiu Libin, Xu Haiting, Carr Sean, Shi Xiaoxiao, Reis Rui L, Kundu Subhas C, Zhu Zhenhua
机构信息
Department of Gastroenterology, the First Affiliated Hospital of Nanchang University, Nanchang 330006, China.
College of Sericulture, Textile, and Biomass Sciences, Southwest University, Chongqing 400715, China.
出版信息
Acta Pharm Sin B. 2024 Sep;14(9):4193. doi: 10.1016/j.apsb.2024.06.005. Epub 2024 Jun 15.
Abstract
[This corrects the article DOI: 10.1016/j.apsb.2024.02.008.].
摘要
[本文更正了文章的数字对象标识符：10.1016/j.apsb.2024.02.008。]
相似文献
1
Erratum: Author correction to "Gas-propelled nanomotors alleviate colitis through the regulation of intestinal immunoenvironment-hematopexis-microbiota circuits" [Acta Pharm Sin B 14 (2024) 2732-2747].勘误：《气体驱动纳米马达通过调节肠道免疫环境-血液结合素-微生物群回路缓解结肠炎》[《药学学报B》14 (2024) 2732-2747]的作者更正。
Acta Pharm Sin B. 2024 Sep;14(9):4193. doi: 10.1016/j.apsb.2024.06.005. Epub 2024 Jun 15.
2
Gas-propelled nanomotors alleviate colitis through the regulation of intestinal immunoenvironment-hematopexis-microbiota circuits.气体驱动的纳米马达通过调节肠道免疫环境-血液结合素-微生物群回路来缓解结肠炎。
Acta Pharm Sin B. 2024 Jun;14(6):2732-2747. doi: 10.1016/j.apsb.2024.02.008. Epub 2024 Feb 12.
3
Erratum: Author correction to 'Pharmacologically targeting molecular motor promotes mitochondrial fission for anti-cancer' [Acta Pharm Sin B 11 (2021) 1853-1866].勘误：“Pharmacologically targeting molecular motor promotes mitochondrial fission for anti-cancer” [《中国药理学报B》11 (2021) 1853-1866]的作者更正。
Acta Pharm Sin B. 2024 May;14(5):2358. doi: 10.1016/j.apsb.2024.02.013. Epub 2024 Feb 21.
4
Erratum: Author correction to 'Co-delivery of nigericin and decitabine using hexahistidine-metal nanocarriers for pyroptosis-induced immunotherapeutics' [Acta Pharm Sin B 12 (2022) 4458-4471].勘误：“使用六组氨酸金属纳米载体共递送尼日利亚菌素和地西他滨用于焦亡诱导的免疫治疗”[《中国药理学报B》12 (2022) 4458 - 4471]的作者更正。
Acta Pharm Sin B. 2024 May;14(5):2359-2360. doi: 10.1016/j.apsb.2024.02.021. Epub 2024 Feb 29.
5
Erratum: Author correction to "Tumor-microenvironment activated duplex genome-editing nanoprodrug for sensitized near-infrared titania phototherapy" [Acta Pharm Sin B (2022) 4224-4234].勘误：《肿瘤微环境激活的双链基因组编辑纳米前药用于敏化近红外二氧化钛光疗》[《药学学报B》（2022年）4224 - 4234]的作者更正。
Acta Pharm Sin B. 2024 Feb;14(2):897-899. doi: 10.1016/j.apsb.2023.09.002. Epub 2023 Sep 7.
6
Erratum: Author correction to "TMEM16A inhibits angiotensin II-induced basilar artery smooth muscle cell migration in a WNK1-dependent manner" [Acta Pharm Sin B 11(12) (2021) 3994-4007].勘误：“TMEM16A以WNK1依赖的方式抑制血管紧张素II诱导的基底动脉平滑肌细胞迁移”[《中国药理学报B》11(12)(2021)3994 - 4007]的作者更正。
Acta Pharm Sin B. 2023 Mar;13(3):1340-1343. doi: 10.1016/j.apsb.2023.01.001. Epub 2023 Feb 2.
7
Erratum: Author correction to 'Amino-functionalized poloxamer 407 with both mucoadhesive and thermosensitive properties: Preparation, characterization and application in vaginal drug delivery system' [Acta Pharm Sin B 7 (2017) 593-602].勘误：《具有黏膜黏附性和热敏性的氨基功能化泊洛沙姆407：制备、表征及其在阴道给药系统中的应用》[《药学学报B》7 (2017) 593 - 602]的作者更正。
Acta Pharm Sin B. 2023 Sep;13(9):3961-3962. doi: 10.1016/j.apsb.2023.06.013. Epub 2023 Jun 28.
8
Erratum: Author correction to '3--Acetyl-11-keto--boswellic acid ameliorated aberrant metabolic landscape and inhibited autophagy in glioblastoma' [Acta Pharm Sin B 10 (2020) 301-312].勘误：对“3 - 乙酰 - 11 - 酮 - β - 乳香酸改善胶质母细胞瘤异常代谢格局并抑制自噬”[《中国药理学通报》10 (2020) 301 - 312]一文的作者校正。
Acta Pharm Sin B. 2024 Aug;14(8):3783-3784. doi: 10.1016/j.apsb.2024.04.025. Epub 2024 Apr 29.
9
Erratum: Author correction to 'Discovery of the radio-protecting effect of ecliptae herba, its constituents and targeting p53-mediated apoptosis and ' [Acta Pharm Sin B 13 (2023) 1216-1230].勘误：《墨旱莲及其成分的辐射防护作用与靶向p53介导的细胞凋亡》的作者更正 [《中国药理学通报》13 (2023) 1216 - 1230] 。
Acta Pharm Sin B. 2023 Jun;13(6):2815-2816. doi: 10.1016/j.apsb.2023.03.026. Epub 2023 Mar 31.
10
Erratum: Author correction to 'FGF4 protects the liver from immune-mediated injury by activating CaMKK-PINK1 signal pathway to inhibit hepatocellular apoptosis' [Acta Pharm Sin B 14 (2024) 1605-1623].勘误：对“FGF4通过激活CaMKK-PINK1信号通路抑制肝细胞凋亡从而保护肝脏免受免疫介导损伤”一文的作者更正[《药学学报B》14 (2024) 1605-1623]。
Acta Pharm Sin B. 2024 Jun;14(6):2791-2793. doi: 10.1016/j.apsb.2024.04.008. Epub 2024 Apr 9.
Zotero 插件